Human trials of Russia’s Covid-19 vaccine, named Sputnik V, will be held in the United Arab Emirates, the second country after Belarus to take part in the programme of which results are expected before the end of November, Moscow said on Monday.
The vaccine, first licensed by Russian authorities for domestic use in August, is currently being tested on 40,000 volunteers in Moscow as part of a late-stage trial known as Phase III. The trial in the UAE has received regulatory approval from the Gulf state’s health ministry, and the process will be supported by local laboratory provider PureHealth, Russia’s sovereign wealth fund, responsible for marketing the vaccine abroad, said in a statement.
‘The results of the UAE trial will be combined with the results of the of the trial in Russia and other countries,’ Kirill Dmitriev, head of the Russian Direct Investment Fund (RDIF) said in the statement, adding that interim results will be published before the end of November. RDIF declined to comment on how many people will receive the jab in the UAE as part of the trial or when it is due to begin.